To validate the role of mpMRI combined to CAD system, to increase prostate cancer detection rate using TRUS-MRI guided biopsy. 167 individuals, with elevated PSA level and no previous positive biopsy were enrolled and 63 underwent targeted biopsy. Two radiologists evaluated the exams adopting PIRADSv2 and CAD system. Radiologists’ evaluation proved better diagnostic performance compared to CAD. The highest detection rate for clinically significant cancer was obtained biopsying “target into target” lesions. CAD system proved to be useful in pinpointing the neoplastic area within MRI lesions, representing a valuable tool in identifying biopsy targets to improve CDR.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords